14-23422291-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM5PP2PP3_StrongPP5
The NM_000257.4(MYH7):c.3134G>A(p.Arg1045His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1045C) has been classified as Pathogenic.
Frequency
Consequence
NM_000257.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH7 | NM_000257.4 | c.3134G>A | p.Arg1045His | missense_variant | 25/40 | ENST00000355349.4 | NP_000248.2 | |
MYH7 | NM_001407004.1 | c.3134G>A | p.Arg1045His | missense_variant | 24/39 | NP_001393933.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH7 | ENST00000355349.4 | c.3134G>A | p.Arg1045His | missense_variant | 25/40 | 1 | NM_000257.4 | ENSP00000347507.3 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251460Hom.: 0 AF XY: 0.0000441 AC XY: 6AN XY: 135904
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461888Hom.: 0 Cov.: 31 AF XY: 0.0000151 AC XY: 11AN XY: 727246
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152164Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74324
ClinVar
Submissions by phenotype
Cardiomyopathy Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Feb 02, 2023 | This missense variant replaces arginine with histidine at codon 1045 of the MYH7 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with hypertrophic cardiomyopathy (PMID: 19659763, 24111713, 26914223, 27247418, 30462978, 31638223, 33241513, 33495597, 33586461, 34330286), arrhythmogenic cardiomyopathy (PMID: 30385303), and dilated cardiomyopathy (PMID: 26199943, 32041989), as well as in a few unaffected family members (PMID: 19659763, 26199943). Some of the affected individuals also carried a pathogenic variant in the same gene (PMID: 31638223) or in other cardiomyopathy-related genes (PMID: 26199943, 30385303), which suggests that this variant was probably not the primary cause of disease in these individuals. This variant has been identified in 10/282840 chromosomes in the general population by the Genome Aggregation Database (gnomAD). Different variants occurring at the same position (p.Arg1045Cys, p.Arg1045Leu) are considered to be disease-causing, indicating that arginine at this position is important for MYH7 function (ClinVar variation ID: 177753, 42948). However, the available evidence is insufficient to determine the role of this p.Arg1045His variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Nov 29, 2022 | - - |
Hypertrophic cardiomyopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 20, 2023 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 1045 of the MYH7 protein (p.Arg1045His). This variant is present in population databases (rs397516178, gnomAD 0.02%). This missense change has been observed in individuals with hypertrophic cardiomyopathy, dilated cardiomyopathy, or arrhythmogenic cardiomyopathy (PMID: 19659763, 24111713, 26199943, 26914223, 27247418, 30385303, 30462978). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 651054). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYH7 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg1045 amino acid residue in MYH7. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18533079, 27247418, 27483260, 27532257). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Hypertrophic cardiomyopathy 1 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PS4_Supporting+PP3_Strong+PM5_Supporting - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 05, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 19659763, 27247418, 24111713, 26914223, 26199943, 30462978, 34598319, 30847666, 30385303, 31638223, 32041989, 31447099, 33586461, 34330286, 35653365, 36095024, 35711818, 36628841) - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 10, 2023 | The p.R1045H variant (also known as c.3134G>A), located in coding exon 23 of the MYH7 gene, results from a G to A substitution at nucleotide position 3134. The arginine at codon 1045 is replaced by histidine, an amino acid with highly similar properties. This variant has been reported in individuals with hypertrophic cardiomyopathy (HCM) and in HCM genetic testing cohorts; however, some of the patients had additional cardiac-related alterations while others had limited clinical details provided (Frisso G et al. Clin. Genet., 2009 Jul;76:91-101; Berge KE et al. Clin. Genet., 2014 Oct;86:355-60; Murphy SL et al. J Cardiovasc Transl Res, 2016 Apr;9:153-61; Cann F et al. Clin Genet, 2017 Jan;91:22-29; Wang B et al. Mol Med Rep, 2019 Dec;20:5229-5238; Filatova EV et al. Mol Genet Genomic Med, 2021 Nov;9:e1808; Wu G et al. J Am Heart Assoc, 2021 Feb;10:e018236; Zhang Y et al. BMC Med Genomics, 2021 Jul;14:196; Beecher G et al. Neurol Genet, 2022 Jun;8:e672; Stava TT et al. Eur J Prev Cardiol, 2022 Oct;29:1789-1799). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at